Interleukin-6 Interacts with Sleep Apnea Severity when Predicting Incident Alzheimer's Disease Dementia.


Journal

Journal of Alzheimer's disease : JAD
ISSN: 1875-8908
Titre abrégé: J Alzheimers Dis
Pays: Netherlands
ID NLM: 9814863

Informations de publication

Date de publication:
2021
Historique:
pubmed: 19 1 2021
medline: 16 9 2021
entrez: 18 1 2021
Statut: ppublish

Résumé

Because of their roles as potential risk factors, we evaluated whether obstructive sleep apnea (OSA) severity interacts with interleukin-6 (IL-6) in predicting incident dementia of the Alzheimer's type (DAT). In 269 dementia-free participants, IL-6 and the apnea-hypopnea index (AHI) were measured at baseline and incident DAT was surveilled for up to 22.8 years. Cox models revealed a significant interaction: In the lowest IL-6 quartile only, a higher AHI was associated with an elevated risk of DAT. The association between OSA severity and incident DAT might be especially apparent in the absence of inflammation or absence of potential benefits from IL-6.

Identifiants

pubmed: 33459710
pii: JAD200545
doi: 10.3233/JAD-200545
pmc: PMC8803404
mid: NIHMS1771685
doi:

Substances chimiques

IL6 protein, human 0
Interleukin-6 0

Types de publication

Letter Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1451-1457

Subventions

Organisme : NIA NIH HHS
ID : R01 AG054076
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201500001C
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG062531
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG008122
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201500001I
Pays : United States
Organisme : NHLBI NIH HHS
ID : N01HC25195
Pays : United States
Organisme : NHLBI NIH HHS
ID : 75N92019D00031
Pays : United States

Références

Neurobiol Dis. 2019 Jan;121:327-337
pubmed: 30336198
Sleep Med Rev. 2020 Apr;50:101250
pubmed: 31881487
Prev Med. 1975 Dec;4(4):518-25
pubmed: 1208363
Sleep Med Rev. 2018 Dec;42:139-148
pubmed: 30241998
Brain Behav Immun. 2018 May;70:61-75
pubmed: 29499302
J Am Geriatr Soc. 2016 Dec;64(12):2472-2478
pubmed: 27801937
Sleep Med Rev. 2017 Aug;34:70-81
pubmed: 27568340
Neurology. 2019 May 14;92(20):e2375-e2384
pubmed: 31004072
Sleep. 1998 Nov 1;21(7):749-57
pubmed: 11286351
ScientificWorldJournal. 2012;2012:756357
pubmed: 22566778
Neurology. 1984 Jul;34(7):939-44
pubmed: 6610841

Auteurs

Andrée-Ann Baril (AA)

The Framingham Heart Study, Framingham, MA, USA.
Department of Neurology, Boston University School of Medicine, Boston, MA, USA.

Alexa S Beiser (AS)

The Framingham Heart Study, Framingham, MA, USA.
Department of Neurology, Boston University School of Medicine, Boston, MA, USA.
Department of Biostatistics, Boston University School of Public Health, Boston, MA, USA.

Susan Redline (S)

Division of Sleep and Circadian Disorders, Brigham & Women's Hospital, Boston, MA, USA.
Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA, USA.
Harvard Medical School, Boston, MA, USA.

Emer R McGrath (ER)

The Framingham Heart Study, Framingham, MA, USA.
HRB Clinical Research Facility, National University of Ireland Galway, Galway, Ireland.

Daniel J Gottlieb (DJ)

Division of Sleep and Circadian Disorders, Brigham & Women's Hospital, Boston, MA, USA.
Harvard Medical School, Boston, MA, USA.
VA Boston Healthcare System, Boston, MA, USA.

Hugo Aparicio (H)

The Framingham Heart Study, Framingham, MA, USA.
Department of Neurology, Boston University School of Medicine, Boston, MA, USA.

Sudha Seshadri (S)

The Framingham Heart Study, Framingham, MA, USA.
Department of Neurology, Boston University School of Medicine, Boston, MA, USA.
Glenn Biggs Institute for Alzheimer's & Neurodegenerative Diseases, University of Texas Health Science Center, San Antonio, TX, USA.

Jayandra J Himali (JJ)

The Framingham Heart Study, Framingham, MA, USA.
Department of Neurology, Boston University School of Medicine, Boston, MA, USA.
Department of Biostatistics, Boston University School of Public Health, Boston, MA, USA.
Glenn Biggs Institute for Alzheimer's & Neurodegenerative Diseases, University of Texas Health Science Center, San Antonio, TX, USA.
Department of Population Health Sciences, University of Texas Health Science Center, San Antonio, TX, USA.

Matthew P Pase (MP)

The Framingham Heart Study, Framingham, MA, USA.
Turner Institute for Brain and Mental Health, School of Psychological Sciences, Monash University, VIC, Australia.
Harvard T.H. Chan School of Public Health, Boston, MA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH